top of page


Time & Location
29 Jul 2025, 4:00 pm – 5:00 pm GMT+8
SR3, SR3, Lab Block, 21 Sassoon Road
About the Event
Background
Immunoengineering has significantly advanced cancer immunotherapy, including CAR-T, and its future prospects are limitless. The current trend of CAR-T application is autoimmune diseases and other CAR effectors in tissue repairing and senolytic. Wenqing Gao opened the new venue of immunoengineering during her training with Jonathan Kipnis. By profiling T-cells in the central nervous system injury, she identified the neuroprotective CD4+ T-cells. mRNA delivery of specific TCR generated such neuroprotective CD4+ T-cells, resulting in CNS injury recovery. This new T-cell therapy for CNS injury is published in Nature, 2024 (Gao et al.).

bottom of page